We are very happy to announce that we have teamed up with BioHorizons as an exclusive partner in the US. BioHorizons is one of the fastest growing companies in the dental industry and a leader in advanced dental implant technologies and tissue regeneration products.
“We look forward to expanding and advancing our existing partnership with BioHorizons in the very important US market. They have excellent knowledge and experience of the US dental implant market and are known for their top-notch customer service and quality, and commitment to education, allowing us to offer our customers the best possible support and partnerships locally”, said Jonas Ehinger, CEO, Osstell.
BioHorizons offers a broad spectrum of products, including dental implants, restorative and laboratory components, soft and hard tissue biologic products and surgical planning software. Osstell is a good fit in their surgical- and implant product portfolios and will contribute to creating substantial value both for dentists and their patients.
We welcome all existing and new customers to contact Biohorizons for any inquiries or additional information.
BioHorizons Inc. a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ: HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, tissue regeneration, and instrument solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit biohorizons.com